← Back to all trials
Not Yet Recruiting
NCT07733440
PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria
Conditions: Prostate Cancer, Risk Assessment, Clinical Decision Support Systems, Predictive Value of Tests, Models, Algorithms, Evidence-Based Practice, Implementation Research, Community Health Services, Primary Health Care, Biomarker, Prostate Specific Antigen, Global Health, Africa, Nigeria
Sex: Male
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 89
Sponsor: Ahmadu Bello University
Location: Ahmadu Bello University Teaching Hospital Zaria Kaduna State
Summary
This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population.
The main questions the validation study aims to answer are:
1. How accurately do existing prostate cancer risk calculators identify Nigerian men with clinically significant prostate cancer?
2. Will a new risk calculator designed for Nigerian men more accurately identify those with clinically significant prostate cancer?
The main questions the intervention study aims to answer is:
Will the primary care provider-facing risk calculator be feasible and acceptable for primary care providers to implement?
The intervention trial will be piloted among participants in community-level hospitals in order to primarily assess implementation outcomes
Eligibility Criteria
Inclusion Criteria:
1. Training - Eligible primary care providers (for the training surveys) will be healthcare practitioners at community-level hospitals.
2. Supported Risk Assessment
(i) Eligible key informants will be eligible primary care providers who were trained and implemented the supported risk assessment and the targeted population of patient participants who received the supported risk assessment.
(ii) Eligible patient participants (for the collection of observation data) will be the target population of adult males 40 - 79 years accessing provider services.
Exclusion Criteria:
\-
Source: ClinicalTrials.gov (NCT07733440). StuddyBuddy aggregates publicly available trial information.